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Abstract
Background: Primary extra-osseous osteogenic sarcomas have been reported in many tissues
of the body but their occurrence in the breast is extremely rare. It can arise as a result of osseous
metaplasia in a pre-existing benign or malignant neoplasm of the breast or as non-phylloides
sarcoma from the soft tissue of a previously normal breast.
Case presentation: A 40 year-old Nigerian woman was clinically diagnosed to have carcinoma
of the left breast. The histology report of core-needle biopsy of the mass showed a malignant
neoplasm comprising islands of chondroblastic and osteoblastic stromal cells. This report
changed the diagnosis from carcinoma to osteogenic sarcoma of the breast. She had a left
modified radical mastectomy, however there was significant post surgery skin deficit. A latissimus
dorsi musculocutaneous flap was used to cover the anterior chest wall defect. Sections from the
mastectomy specimen confirmed the diagnosis of osteogenic sarcoma. She died six months after
mastectomy.
Conclusion: A diagnosis of osteogenic sarcoma of the breast was made based on histology
report and after excluding an osteogenic sarcoma arising from underlying ribs and sternum. This
is the second documented case of primary osteogenic sarcoma of the breast coming from
Nigeria
Background
Breast cancer is the commonest cancer that afflicts
females worldwide. In Cancer Statistics 2005, breast can-
cer remains the leading cancer among American women
with an estimate of 32% excluding skin cancers [1]. Of
all the cancers of the breast, carcinoma forms the bulk
while breast sarcomas are negligible [2,3]. Extra-skeletal
osteosarcoma has been documented in many tissues of
the body including the thyroid gland, kidney, bladder,
colon, heart, testis, penis, gall bladder and the cerebel-
lum [4-10]. When it occurs in the breast, it originates
either from normal breast tissue de novo, or as metaplas-
tic differentiation of a primary benign or malignant
breast lesion. Osteogenic sarcomas of the breast either
arising primarily in the breast or as secondary deposits
from primary bone sarcomas occur in very rare cases.
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World Journal of Surgical Oncology 2006, 4:90 http://www.wjso.com/content/4/1/90Almost every previous reference to this entity in literature
is in form of single case reports. In almost all cases, the
patients had been diagnosed clinically as having breast
carcinoma and the correct tissue diagnosis was established
by histology [11,12]. The largest collection of primary
breast osteogenic sarcomas found on Pubmed search
from 1967 to date was a clinico-pathological analysis of
50 cases seen over a 38-year period and reported by Silver
and Tavassoli in 1998 [13]. This paper reports the case of
a young woman who presented with recurrent left breast
lump which was clinically diagnosed as carcinoma but
turned out to be osteogenic sarcoma arising from the
breast.
Case presentation
A 40 year-old Nigerian housewife was seen at the oncol-
ogy clinic of the University College Hospital (UCH)
Ibadan, Nigeria in June 2002 with a 1 year 8 months his-
tory of painful left breast lump which had been previously
excised in another hospital but recurred 8 months before
presentation at UCH. There was no information about
histological diagnosis of the excised breast lesion from the
first hospital. There were no systemic symptoms. She was
Para 7+1 and had no family history of breast or ovarian
cancer. Physical examination revealed globular enlarge-
ment of the left breast measuring 20 cm × 18 cm. The mass
occupied the whole breast, was warm, multinodular and
fixed to the pectoralis fascia. The ipsilateral axillary lymph
nodes were enlarged, but examination of the other sys-
tems was normal. A clinical diagnosis of locally advanced
cancer of the left breast was made.
Plain radiograph of the chest and abdominal ultrasound
scan were normal. A core-needle biopsy of the mass was
done and histology showed a malignant neoplasm com-
prising islands of chondroblastic and osteoblastic stromal
cells, with no normal breast tissue seen. A diagnosis of
osteogenic sarcoma was made. The patient had a left mod-
ified radical mastectomy and latissimus dorsi musculocuta-
neous flap to cover an anterior chest wall defect. The
mastectomy specimen weighed 350 g. Cut sections
revealed areas of cystic degeneration and necrosis, with
focal areas that were firm with a cartilaginous consistency.
Conventional representative sections were obtained from
each of the four breast quadrants, areola region, resection
margins and axillary lymph nodes. Microscopic examina-
tion of the sections showed a malignant breast neoplasm
displaying fibrosarcomatous, chondrosarcomatous (Fig-
ure 1) as well as osteosarcomatous (Figure 2) differentia-
tion. There was metastasis to one of the lymph nodes. She
was scheduled for radiotherapy to the chest wall but she
defaulted. Contact tracing revealed that she died about 6
months after mastectomy.
Discussion
Osteogenic sarcoma of the breast tissue can arise from a
pre-existing benign or malignant neoplasm of the breast
or may arise from previously normal breast tissue as non-
phylloides sarcoma. It is known to differentiate from the
connective tissue elements of fibroadenomas and has
been reported following intraductal papilloma [3,14].
Breast osteosarcoma can also arise as an osseous metapla-
sia of a primary carcinoma of the breast and as a whole or
partial metaplastic replacement of phylloides tumor
stroma [15,16]. In its pure form and in exceptional cases,
osteogenic sarcoma can arise from the soft tissues of a pre-
viously normal breast [17]. To diagnose primary breast
osteosarcoma, an osteogenic sarcoma arising from the
underlying chest wall bony cage and infiltrating the breast
tissue must be excluded. From findings at surgery and
from the pathology report, our patient did not have gross
or microscopic chest wall osteosarcoma extending to the
breast. The absence of demonstrable metaplastic transfor-
mation of a pre-existing fibroadenoma or phylloides
tumor at histology among others, suggests that the case
presented could be an example of breast sarcoma arising
from previously normal breast tissue.
Photomicrograph from breast neoplasm displaying cartilagi-nous diffe entiation f malignant stromal elements (Hema-t xylin-eosi , × 440)Figure 1
Photomicrograph from breast neoplasm displaying cartilagi-
nous differentiation of malignant stromal elements (Hema-
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World Journal of Surgical Oncology 2006, 4:90 http://www.wjso.com/content/4/1/90Almost all patients with osteogenic sarcoma present like
those with other benign or malignant breast lesions. Clin-
ically, the breast lump is of varying consistency and may
be rapidly growing. At the time of presentation, most
patients have developed metastasis in different parts of
the body including the chest and bones, though this was
not the case with our patient [18]. The two patients from
our centre – this case and the earlier reported one [11] –
presented for definitive treatment about one year after
noticing breast lumps and when the tumors were already
locally advanced. This is typical of breast cancer patients
about 80 percent of who present late to our oncology
clinic [19]. Mammographic findings vary. Most present as
large masses with relatively well-defined margins and lob-
ulated borders, often containing coarse or dense calcifica-
tions, which are sometimes similar to fibroadenomas
[20]. Where available intense focal intake of 99mTc-
diphosphonate, a specific radionuclide marker for osteoid
tumoral tissue, in a soft-tissue tumor is strongly suggestive
of bone-forming neoplasms. This may be useful in the
radiological diagnosis of breast osteosarcoma [20-22].
Serum alkaline phosphatase is known to be elevated in
patients with osteoid-forming neoplasms [20]. Though
non-specific, these tests may be useful adjuncts in the
diagnosis of osteogenic sarcoma of the breast. Definitive
diagnosis hinges on exclusion of an osteogenic sarcoma
arising from underlying ribs and sternum, and a demon-
stration of osteosarcomatous matrix by histology. Where
facilities are available, immunohistochemical demonstra-
tion of vimentin with absence of epithelial, neural, mus-
cular and other markers suggest the diagnosis of
osteogenic sarcoma. This may be confirmed by ultrastruc-
tural examination of the osteoid-like areas, which will
reveal collagen fibers enmeshed with crystalline material
confirming the presence of osteoid [23].
The rarity of this condition precludes any one institution
from gathering enough cases from which a definitive
assessment of the effectiveness of treatment options can
be made or clinical trials conducted. It follows however,
that management of sarcomas elsewhere should generally
apply in the management of this disease entity. It is debat-
able whether modified radical mastectomy should be
done instead of simple mastectomy with axillary node
dissection where there is clinical evidence of lymph node
involvement. Adequate surgical excision should ensure
tumor free margins and be supplemented by intraopera-
tive evaluation of lymph nodes. Osteosarcomas are
aggressive tumors with a propensity for blood-borne
rather than lymphatic spread [13]. Because of high risk of
recurrence, chest wall irradiation and regular follow-up
for early detection of loco-regional recurrence is indicated.
The role of combination chemotherapy is uncertain but it
may be considered in the presence of systemic metastasis.
However, these have not been proven to offer additional
benefits.
Because these tumors tend to attain large sizes and the role
of neoadjuvant chemotherapy to down-stage them is
unclear, patients occasionally require chest wall recon-
struction. Myocutaneous flaps are preferred because they
can tolerate radiotherapy with minimal risk of tissue loss
[24-27]. Latissimus dorsi musculocutaneous flap was used
for our patient because of the ease of raising it, its reliabil-
ity and cosmetic acceptability of the scar at the donor site,
which is hidden at the back of the patient where it is cov-
ered with regular clothing. The major disadvantage of the
flap is that patient may have to be repositioned during the
course of surgery to ensure improved access.
Conclusion
We report here another case of osteosarcoma of the breast
where definitive diagnosis was made based on histology
report and after excluding an osteogenic sarcoma arising
from underlying ribs and sternum. To date, adequate sur-
gical excision is the best form of treatment that offers the
best outlook for patients. Its rarity, however, should not
Photomicrograph from tumor displaying osteoid deposition by the malignant st al cells (Hematoxylin-eosin, × 440)Figure 2
Photomicrograph from tumor displaying osteoid deposition 
by the malignant stromal cells (Hematoxylin-eosin, × 440).Page 3 of 4
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prevent oncologists from following up on the literature of
the disease to keep abreast of new cases and possibly new
developments.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
TOO, SAA and OMO took part in the care of the patient.
EEA examined surgical specimen and took photomicro-
graphs of the slides. TOO initiated and co-wrote the paper
with SAA, CAA and EEA. All authors read and approved
the final manuscript.
Acknowledgements
Written consent was obtained from a relative of the patient for the publi-
cation of this report.
References
1. American Cancer Society: Cancer Statistics 2005.  Estimated US
Cancer Cases  [http://www.cancer.org/downloads/STT/282,12,2005].
2. McPherson K, Steel CM, Dixon JM: ABC of breast diseases,
breast cancer epidemiology, risk factors, and genetics.  BMJ
2000, 321:624-628.
3. Benediktsdottir K, Lagerberg F, Lundell L, Thulin A: Osteogenic sar-
coma of the breast. Report of a case.  Acta Pathol Microbiol Scand
1980, 88A:161-165.
4. Mertens HH, Langnickel D, Staedtler F: Primary osteogenic sar-
coma of the breast.  Acta Cytologica 1982, 26:512-516.
5. Shimazu K, Funata N, Yamamoto Y, Mori T: Primary osteosar-
coma arising in the colon: report of a case.  Dis Colon Rectum
2001, 44:1367-1370.
6. Minami H, Wakita N, Kawanishi Y, Kitano I, Sakata M, Shida T: Pri-
mary osteosarcoma of heart with severe congestive heart
failure.  Jpn J Thorac Cardiovasc Surg 2000, 48:607-609.
7. Lee JS, Choi YD, Choi C: Primary testicular osteosarcoma with
hydrocele.  Virchow's Arch 2004, 445:210-213.
8. Sacker AR, Oyama KK, Kessler S: Primary osteosarcoma of the
penis.  Am J Dermatopathol 1994, 16:285-287.
9. Olgyai G, Horvath V, Kocsis J, Buza N, Olah A: Extraskeletal oste-
osarcoma in the gallbladder.  Magy Seb 2003, 56:57-60.
10. Cannon TC, Bane BL, Kistler D, Schoenhals GW, Hahn M, Leech RW,
Brumback RA: Primary intracerebellar osteosarcoma arising
within an epidermoid cyst.  Arch Pathol Lab Med 1998,
122:737-739.
11. Oluwasola AO, Adebamowo CA, Ezeome ER, Oduntan O, Akang EE:
Osteogenic sarcoma of the breast: Case report of a diagnos-
tic dilemma.  Afr J Med Med Sci 2000, 30:129-131.
12. Hosoi H, Yoshioka M, Tanaka Y, Wada I, Nakao M, Maeda S, Onda M:
Primary osteogenic sarcoma of the breast. Report of a case.
Nippon Geka Gakkai Zasshi 1989, 90:1262-1265.
13. Silver SA, Tavassoli FA: Primary osteogenic sarcoma of the
breast: a clinicopathologic analysis of 50 cases.  Am J Surg Pathol
1998, 22:925-933.
14. Remadi S, Doussis-Anagnostopoulu I, MacGee W: Primary oste-
osarcoma of the breast.  Pathol Res Pract 1995, 191:471-474.
15. Suzuki T, Kikuchi K, Horiguchi Y, Nihei K, Asano S: Breast carci-
noma with features of osteosarcoma-a light and electron
microscopic and immunohistochemical study.  Jap J Cancer Clin
1989, 35:1453-1460.
16. Silver SA, Tavassoli FA: Osteosarcomatous differentiation in
phyllodes tumors.  Am J Surg Pathol 1999, 23:815-821.
17. Arraztoa J, Oddo D, San Martin S, Arraztoa JA, Becker P, Valuenzela
J: Unusual sarcomas of the breast. Report of 3 cases.  Revista
Medica de Chile 1989, 117:435-439.
18. Momoi H, Wada Y, Sarumaru S, Tamaki N, Gomi T, Kanaya S,
Katayama T, Ootoshi M, Fukumoto M: Primary osteosarcoma of
the breast.  Breast Cancer 2004, 11:396-400.
19. Adebamowo CA, Ajayi OO: Breast cancer in Nigeria.  West Afr J
Med 2000, 19:179-191.
20. Sabaté JM, Gomez A, Torrubia S, Flotats A: Osteosarcoma of the
Breast.  Am J Roentgenol 2002, 179:277-278.
21. Lumsden AB: Demonstration of a primary bone tumor of the
breastby technetium-99m diphosphonate bone imaging.  Clin
Nucl Med 1986, 11:362.
22. Lee JK, Sun SS: Primary osteogenic sarcoma of the breast
demonstrated by Tc-99m MDP scintigraphy.  Clin Nucl Med
1998, 23:619.
23. Staddon AP, Lackman R, Robinson K, Shrager JB, Warhol M: Osteo-
genic sarcoma presenting with lung metastasis.  The Oncologist
2002, 7:144-153.
24. Mehta VK, Goffinet D: Post mastectomy radiation therapy
after TRAM flap breast reconstruction.  Breast J 2004,
10:118-122.
25. Knottenbelt A, Spauwen PH, Wobbes T: The oncological implica-
tion of immediate breast reconstruction.  Eur J Surg Oncol 2004,
30:829-833.
26. Mansour KA, Anderson TM, Hester TR: Sternal resection and
reconstruction.  Ann Thorac Surg 1993, 55:838-842.
27. Ramming KP, Holmes EC, Zarem HA, Lesavoy MA, Morton DL: Sur-
gical management and reconstruction of extensive chest
malignancies.  Am J Surg 1982, 144:146-152.Page 4 of 4
(page number not for citation purposes)
